First Rapid COVID-19 Antigen Test Gets Green Light

11 May 2020

In a potential game-changer in the ongoing fight to expand COVID-19 testing, the FDA has authorized a new kind of test that can be used by certain health care providers on-site to diagnose patients with the SARS-CoV-2 virus within minutes instead of days.

Sofia2 combo photo — Quidel’s Sofia 2 SARS Antigen FIA test is the first rapid point-of-care test to be authorized in the US. • Source: Quidel Corp.

First Rapid COVID-19 Antigen Test Gets Green Light

More from Regulation

More from Policy & Regulation